Neurology Central

The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine


For psychiatric disorders, repeated failures in converting scientific discoveries into novel drugs has precipitated a crisis and eroded confidence in drug discovery. This review describes how current and future innovations driven by application of biomarkers can help to re-initiate research in this area. This will have a positive impact on the field of psychiatry and result in application of sensitive and specific biochemical tests in parallel with the traditional questionnaires for improved diagnosis.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.